Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma

Abstrakt

The study confirmed that strategy aimed at reducing of sputum eosinophils (EOS strategy) in comparison with standard strategy (GIIVA guidellines) leads to better clinical control and lower exaxerbation rate.